It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Type 2 Diabetes Mellitus has reached epidemic levels globally, and several studies have confirmed a link between gut microbial dysbiosis and aberrant glucose homeostasis among people with diabetes. While the assumption is that abnormal metabolomic signatures would often accompany microbial dysbiosis, the connection remains largely unknown. In this study, we investigated how diet changed the gut bacteriome, mycobiome and metabolome in people with and without type 2 Diabetes.1 Differential abundance testing determined that the metabolites Propionate, U8, and 2-Hydroxybutyrate were significantly lower, and 3-Hydroxyphenyl acetate was higher in the high fiber diet compared to low fiber diet in the healthy control group. Next, using multi-omics factor analysis (MOFA2), we attempted to uncover sources of variability that drive each of the different groups (bacterial, fungal, and metabolite) on all samples combined (control and DM II). Performing variance decomposition, ten latent factors were identified, and then each latent factor was tested for significant correlations with age, BMI, diet, and gender. Latent Factor1 was the most significantly correlated. Remarkably, the model revealed that the mycobiome explained most of the variance in the DM II group (12.5%) whereas bacteria explained most of the variance in the control group (64.2% vs. 10.4% in the DM II group). The latent Factor1 was significantly correlated with dietary intake (q < 0.01). Further analyses of the impact of bacterial and fungal genera on Factor1 determined that the nine bacterial genera (Phocaeicola, Ligilactobacillus, Mesosutterella, Acidaminococcus, Dorea A, CAG-317, Caecibacter, Prevotella and Gemmiger) and one fungal genus (Malassezia furfur) were found to have high factor weights (absolute weight > 0.6). Alternatively, a linear regression model was fitted per disease group for each genus to visualize the relationship between the factor values and feature abundances, showing Xylose with positive weights and Propionate, U8, and 2-Hydroxybutyrate with negative weights. This data provides new information on the microbially derived changes that influence metabolic phenotypes in response to different diets and disease conditions in humans.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Khalifa University of Science and Technology, Department of Genetics and Molecular Biology, College of Medicine and Health Sciences, Abu Dhabi, UAE (GRID:grid.440568.b) (ISNI:0000 0004 1762 9729); Khalifa University of Science and Technology, Center for Biotechnology, Abu Dhabi, UAE (GRID:grid.440568.b) (ISNI:0000 0004 1762 9729)
2 University of Lübeck, Lübeck Institute of Experimental Dermatology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672); University of Lübeck, Institute for Cardiogenetics, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
3 University of Sharjah, Department of Clinical Sciences, College of Medicine, Sharjah, UAE (GRID:grid.412789.1) (ISNI:0000 0004 4686 5317)
4 University of Lübeck, Institute of Nutritional Medicine, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
5 Khalifa University of Science and Technology, Department of Genetics and Molecular Biology, College of Medicine and Health Sciences, Abu Dhabi, UAE (GRID:grid.440568.b) (ISNI:0000 0004 1762 9729); Khalifa University of Science and Technology, Center for Biotechnology, Abu Dhabi, UAE (GRID:grid.440568.b) (ISNI:0000 0004 1762 9729); University of Lübeck, Lübeck Institute of Experimental Dermatology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672); University of Lübeck, Institute of Nutritional Medicine, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)